Cenix BioScience and Schering AG Sign Research Agreements to Advance Several Disease Programs
Cenix BioScience GmbH and Schering AG announced that they have signed research service agreements to accelerate the latter¹s target discovery and validation efforts in several human disease programs.
Both projects, which started in the last quarter of 2004, focus on the cell-based validation by Cenix of collections of candidate genes previously identified by Schering AG as possible therapeutic drug targets. Cenix is applying its industry-leading expertise in combining high throughput (HT) RNAi with high content (HC) phenotype analyses in mammalian cells to deliver an efficient, detailed characterization of target-specific loss-of-function phenotypes. These data, along with associated insights into the functions of these targets, will provide Schering AG with the solid, patho-physiologically relevant criteria needed to prioritize targets for advancement in their drug development programs.
Cenix will apply streamlined HT validation of RNAi reagents and proprietary HT-RNAi assays including functional readouts based on rich, multi-parameter analyses. The project, which will make use of several human and mouse cell lines, will advance research programs at Schering AG. No financial terms were disclosed.
Other news from the department business & finance
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
